ERC Proof of Concept Grant for Developing ReproTox
Professor Susana Chuva de Sousa Lopes at the Leiden University Medical Center partnered with Toxys and received a European Research Council Proof of Concept grant for developing ReproTox. This novel human stem cell-based assay will enable screening chemicals and environmental factors for their potential toxic...
Create2Solve Funded Consortium Annual Progress Meeting
Toxys is one of the five partners in the ‘Better in vitro dosing’ consortium, funded by ZonMw’s Create2Solve subsidy program. The aim of the project is to develop alternative dosing technologies for in vitro assays to better reflect human exposure. These novel dosing approaches should...
Toxys publication on OECD ring trial validation of ToxTracker
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE Toxys reports positive results from the OECD ring trial validation of ToxTracker in a peer-reviewed article Oegstgeest, The Netherlands. April 9th, 2024 - Today Toxys announces the peer-reviewed publication of the positive results from an international interlaboratory validation of ToxTracker©. ToxTracker is an in...
Toxys Awarded Phase 1 Project in CRACK IT Challenge
CRACK IT is a challenge-led competition that funds collaborations between industry, academics and SMEs to solve business and scientific Challenges which will deliver 3Rs benefits, either by improving business processes or developing a commercial product. Depending on the Challenge, contracts of up to £1M for...
OECD Peer-Review of the Interlaboratory Validation of ToxTracker
[vc_row][vc_column][vc_column_text]In Q3 2023, the OECD has conducted the peer-review of the interlaboratory validation of the ToxTracker assay by a panel of experts, nominated by their National Coordinators. A report on the successful ToxTracker validation results was recently published on the OECD website. Significance of the validation The...
Join us at our ToxTracker hands-on training workshop!
[vc_row][vc_column][vc_column_text] Dates: 12 - 13 October 2023 Venue: Toxys B.V., De Limes 7, Oegstgeest, The Netherlands 2342 DH Join us for a hands-on training workshop on ToxTracker! ToxTracker is a unique genotoxicity assay that can reliably identify genotoxic compounds and can provide detailed insight into their mode-of-action. During the...
Labstat Inc., a Certified Group Company, partners with Toxys to offer the ToxTracker® assay
[vc_row][vc_column][vc_column_text] TORONTO, March 15, 2023 – Labstat Inc., A Certified Group Company, has entered into a partnership with Toxys to offer the ToxTracker assay at its Kitchener, Ontario laboratory. ToxTracker is a state-of-the-art stem cell-based reporter assay that provides mechanistic insights into the mode of action...
IIVS and Toxys enter into agreement to offer ToxTracker® for in vitro genetic toxicity evaluation
[vc_row][vc_column][vc_column_text] IIVS will offer ToxTracker®, expanding its portfolio of animal-free genetic toxicology assays Gaithersburg, M.D., USA, and Oegstgeest, The Netherlands, March 9, 2023 – The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker® assay....
The ReproTracker team wins the EPAA Science Prize 2022!
We are very proud that Dr Amer Jamalpoor, study director of ReproTracker and lead scientist in developmental toxicology, was awarded the EPAA European Partnership for Alternatives Science Prize 2022 for outstanding contributions towards animal-alternative testing methods. The awarded case study, “ReproTracker: an animal-free platform for developmental...
Toxys is scaling up in the US
After establishing a Toxys subsidiary in the US last year, we are scaling up our business at Toxys Inc. We have hired a Director of BD & Sales to expand our commercial activities and officially started the production of our ToxTracker kits and reagents in...
